SCHEMBL29790097

SCHEMBL29790097

C1=CC=CC=CC=CC=CC=CC=COC=CN=CC=CC=CC=CC=CC=CC=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31304810 1.00
SCHEMBL31304955 1.00
SCHEMBL30200881 1.00
SCHEMBL38663499 0.97
SCHEMBL2779452 0.88
Hydrochloric Acid SCHEMBL26625489 0.86
Hydrochloric Acid SCHEMBL29558253 0.86
SCHEMBL28008807 0.86
SCHEMBL31570731 0.83
SCHEMBL29935635 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174615-A1 SYNTHESIS OF RAPAMYCIN ANALOG COMPOUNDS WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT 2024-05-30 US disclosed
EP-3999087-A1 SECOND GENERATION SENECA VALLEY VIRUS ONCOLYTIC THERAPY: COMPOSITIONS AND METHODS THEREOF The Trustees of Columbia University in the City of New York (US) 2022-05-25 EP disclosed